246 related articles for article (PubMed ID: 34195678)
1. A muscle fatigue-like contractile decline was recapitulated using skeletal myotubes from Duchenne muscular dystrophy patient-derived iPSCs.
Uchimura T; Asano T; Nakata T; Hotta A; Sakurai H
Cell Rep Med; 2021 Jun; 2(6):100298. PubMed ID: 34195678
[TBL] [Abstract][Full Text] [Related]
2. Acute conversion of patient-derived Duchenne muscular dystrophy iPSC into myotubes reveals constitutive and inducible over-activation of TGFβ-dependent pro-fibrotic signaling.
Caputo L; Granados A; Lenzi J; Rosa A; Ait-Si-Ali S; Puri PL; Albini S
Skelet Muscle; 2020 May; 10(1):13. PubMed ID: 32359374
[TBL] [Abstract][Full Text] [Related]
3. Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells.
Shoji E; Sakurai H; Nishino T; Nakahata T; Heike T; Awaya T; Fujii N; Manabe Y; Matsuo M; Sehara-Fujisawa A
Sci Rep; 2015 Aug; 5():12831. PubMed ID: 26290039
[TBL] [Abstract][Full Text] [Related]
4. Contractile Activity of Myotubes Derived from Human Induced Pluripotent Stem Cells: A Model of Duchenne Muscular Dystrophy.
Yoshioka K; Ito A; Horie M; Ikeda K; Kataoka S; Sato K; Yoshigai T; Sakurai H; Hotta A; Kawabe Y; Kamihira M
Cells; 2021 Sep; 10(10):. PubMed ID: 34685536
[TBL] [Abstract][Full Text] [Related]
5. A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells.
Young CS; Hicks MR; Ermolova NV; Nakano H; Jan M; Younesi S; Karumbayaram S; Kumagai-Cresse C; Wang D; Zack JA; Kohn DB; Nakano A; Nelson SF; Miceli MC; Spencer MJ; Pyle AD
Cell Stem Cell; 2016 Apr; 18(4):533-40. PubMed ID: 26877224
[TBL] [Abstract][Full Text] [Related]
6. Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9.
Li HL; Fujimoto N; Sasakawa N; Shirai S; Ohkame T; Sakuma T; Tanaka M; Amano N; Watanabe A; Sakurai H; Yamamoto T; Yamanaka S; Hotta A
Stem Cell Reports; 2015 Jan; 4(1):143-154. PubMed ID: 25434822
[TBL] [Abstract][Full Text] [Related]
7. De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle.
Ebrahimi M; Lad H; Fusto A; Tiper Y; Datye A; Nguyen CT; Jacques E; Moyle LA; Nguyen T; Musgrave B; Chávez-Madero C; Bigot A; Chen C; Turner S; Stewart BA; Pegoraro E; Vitiello L; Gilbert PM
Acta Biomater; 2021 Sep; 132():227-244. PubMed ID: 34048976
[TBL] [Abstract][Full Text] [Related]
8. Nanotopography-responsive myotube alignment and orientation as a sensitive phenotypic biomarker for Duchenne Muscular Dystrophy.
Xu B; Magli A; Anugrah Y; Koester SJ; Perlingeiro RCR; Shen W
Biomaterials; 2018 Nov; 183():54-66. PubMed ID: 30149230
[TBL] [Abstract][Full Text] [Related]
9. Prednisolone rescues Duchenne muscular dystrophy phenotypes in human pluripotent stem cell-derived skeletal muscle in vitro.
Al Tanoury Z; Zimmerman JF; Rao J; Sieiro D; McNamara HM; Cherrier T; Rodríguez-delaRosa A; Hick-Colin A; Bousson F; Fugier-Schmucker C; Marchiano F; Habermann B; Chal J; Nesmith AP; Gapon S; Wagner E; Gupta VA; Bassel-Duby R; Olson EN; Cohen AE; Parker KK; Pourquié O
Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34260377
[TBL] [Abstract][Full Text] [Related]
10. Dantrolene enhances antisense-mediated exon skipping in human and mouse models of Duchenne muscular dystrophy.
Kendall GC; Mokhonova EI; Moran M; Sejbuk NE; Wang DW; Silva O; Wang RT; Martinez L; Lu QL; Damoiseaux R; Spencer MJ; Nelson SF; Miceli MC
Sci Transl Med; 2012 Dec; 4(164):164ra160. PubMed ID: 23241744
[TBL] [Abstract][Full Text] [Related]
11. Effects of Mini-Dystrophin on Dystrophin-Deficient, Human Skeletal Muscle-Derived Cells.
Meng J; Counsell J; Morgan JE
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998454
[TBL] [Abstract][Full Text] [Related]
12. A Novel CRISPR-Cas9 Strategy to Target DYSTROPHIN Mutations Downstream of Exon 44 in Patient-Specific DMD iPSCs.
Dhoke NR; Kim H; Azzag K; Crist SB; Kiley J; Perlingeiro RCR
Cells; 2024 Jun; 13(11):. PubMed ID: 38891104
[TBL] [Abstract][Full Text] [Related]
13. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
[TBL] [Abstract][Full Text] [Related]
14. Mimicking sarcolemmal damage
Tejedera-Villafranca A; Montolio M; Ramón-Azcón J; Fernández-Costa JM
Biofabrication; 2023 Sep; 15(4):. PubMed ID: 37725998
[TBL] [Abstract][Full Text] [Related]
15. Functional significance of gain-of-function H19 lncRNA in skeletal muscle differentiation and anti-obesity effects.
Li Y; Zhang Y; Hu Q; Egranov SD; Xing Z; Zhang Z; Liang K; Ye Y; Pan Y; Chatterjee SS; Mistretta B; Nguyen TK; Hawke DH; Gunaratne PH; Hung MC; Han L; Yang L; Lin C
Genome Med; 2021 Aug; 13(1):137. PubMed ID: 34454586
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-mediated correction of skeletal muscle Ca
Morera C; Kim J; Paredes-Redondo A; Nobles M; Rybin D; Moccia R; Kowala A; Meng J; Garren S; Liu P; Morgan JE; Muntoni F; Christoforou N; Owens J; Tinker A; Lin YY
Neuromuscul Disord; 2022 Dec; 32(11-12):908-922. PubMed ID: 36418198
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line carrying a deletion of exons 51-53 of the dystrophin gene (CCMi003-A).
Rovina D; Castiglioni E; Farini A; Bellichi M; Gervasini C; Paganini S; Di Segni M; Santoro R; Torrente Y; Pompilio G; Gowran A
Stem Cell Res; 2019 Oct; 40():101544. PubMed ID: 31465894
[TBL] [Abstract][Full Text] [Related]
18. Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human-induced pluripotent stem cells.
Pioner JM; Guan X; Klaiman JM; Racca AW; Pabon L; Muskheli V; Macadangdang J; Ferrantini C; Hoopmann MR; Moritz RL; Kim DH; Tesi C; Poggesi C; Murry CE; Childers MK; Mack DL; Regnier M
Cardiovasc Res; 2020 Feb; 116(2):368-382. PubMed ID: 31049579
[TBL] [Abstract][Full Text] [Related]
19. Targeted addition of mini-dystrophin into rDNA locus of Duchenne muscular dystrophy patient-derived iPSCs.
Zeng B; Zhou M; Liu B; Shen F; Xiao R; Su J; Hu Z; Zhang Y; Gu A; Wu L; Liu X; Liang D
Biochem Biophys Res Commun; 2021 Mar; 545():40-45. PubMed ID: 33540285
[TBL] [Abstract][Full Text] [Related]
20. ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs.
Hicks MR; Hiserodt J; Paras K; Fujiwara W; Eskin A; Jan M; Xi H; Young CS; Evseenko D; Nelson SF; Spencer MJ; Handel BV; Pyle AD
Nat Cell Biol; 2018 Jan; 20(1):46-57. PubMed ID: 29255171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]